2m 2m 2m 2m 2m 2m 2m
VERU (VERU)
NASDAQ
$2.61+$0.05 (+1.95%)
Price as of Jul 14, 2026 8:39 AM EDT- $41.1MMarket Cap
- -57.65%1-Year Change
- BiotechnologyIndustry
VERU (VERU)
$2.61+$0.05 (+1.95%)
VERU | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.56 | ||
Change | -$0.22 (-7.91%) | ||
Open | $2.74 | ||
High | $2.75 | ||
Low | $2.50 | ||
Previous Close | $2.78 | ||
Volume | 397,912 | ||
30-Day Average Volume | 361,262 | ||
1-Week Change | -9.54% | ||
1-Month Change | -14.67% | ||
1-Year Change | -57.65% | ||
3-Year Change | -79.68% | ||
5-Year Change | -96.45% | ||
Fundamentals | |||
Shares Outstanding | 16.1M | ||
Total Assets | $43.1M | ||
Market Cap | $41.1M | ||
Enterprise Value | $13.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$2.7M | ||
Free Cash Flow | -$8.9M | ||
EBIT | -$2.7M | ||
EBITDA | -$2.7M | ||
Net Working Capital | $28.0M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -21 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 04/28/2014 | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 08/11/2025 | ||
Earnings & Revenue